Elevated plasma levels of endostatin are associated with chronic kidney disease.
about
Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease.Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients.Remnant nephron physiology and the progression of chronic kidney disease.The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?Renal allograft fibrosis: biology and therapeutic targets.Assessment of plasma endostatin to predict acute kidney injury in critically ill patients.The Relation between Serum Endostatin Level and Carotid Atherosclerosis in Healthy Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS).Endostatin: a promising biomarker in the cardiovascular continuum?Biomarkers of acute kidney injury - a mission impossible?Association of the Serum Endostatin Level, Renal Function, and Carotid Atherosclerosis of Healthy Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS).An extracellular proteasome releases endostatin from human collagen XVIII.The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS).The GG genotype of the -152 G/A vascular endothelial growth factor (VEGF) polymorphism predisposes to hypertension-related chronic kidney disease.Biomarker for early renal microvascular and diabetic kidney diseases.
P2860
Q34166007-28FDFD96-4E68-4189-A564-A9D8AACFA9B6Q36220259-BF31A474-6E28-47B8-B773-EE91289F54C4Q36460290-387083FB-6A6D-439F-AE1A-AF6CBDBCD0FDQ37228467-CAEB9289-80D6-488F-A689-0BA466156597Q37702664-49FBAE49-B8F6-4A34-9D7A-12E4C74E5186Q38359455-0B1421E9-3C23-4A5F-9352-638BD0839DC7Q38600681-82280C6B-74D3-4AEC-959B-BA84281F915CQ38827707-74B3D371-F8A6-48AD-A2A7-766CCE995635Q47667458-1C65717F-A708-4DF0-9B08-2F795997A8E9Q48170454-8973B377-0DD2-48A1-B490-3BF91AC8223BQ49339392-170678C4-4197-4E88-8C5E-940561101AE7Q51283766-7E670D2C-3561-49AB-8440-3B06C14BE70FQ51287294-44D932E7-3D38-40A3-806F-EE8F3E720E1AQ51660786-E79291B2-40A6-455F-8BE2-BA5428D522D0Q53740601-59BA57DE-EA85-45DE-A5BD-A4F42D3DC9F8
P2860
Elevated plasma levels of endostatin are associated with chronic kidney disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Elevated plasma levels of endostatin are associated with chronic kidney disease.
@ast
Elevated plasma levels of endostatin are associated with chronic kidney disease.
@en
type
label
Elevated plasma levels of endostatin are associated with chronic kidney disease.
@ast
Elevated plasma levels of endostatin are associated with chronic kidney disease.
@en
prefLabel
Elevated plasma levels of endostatin are associated with chronic kidney disease.
@ast
Elevated plasma levels of endostatin are associated with chronic kidney disease.
@en
P2093
P2860
P356
P1476
Elevated plasma levels of endostatin are associated with chronic kidney disease.
@en
P2093
Chung-Shiuan Chen
Eric E Simon
Fred Husserl
Islam Enver Khan
Katherine T Mills
L Lee Hamm
Myra A Kleinpeter
P2860
P304
P356
10.1159/000336109
P577
2012-03-27T00:00:00Z